MARKSANS PHARMA Fundamental Report

SHARE PRICE

Get to know the company overview of MARKSANS - face value, book value, exchange symbol, 1 year & lifetime highs/lows, average volume, market cap, PE ratio, 1 month return, % promoter holding pledged before investing in MARKSANS

Current Price (Rs.) 14.65
Face Value (Rs.) 1
Book Value (Rs.) 13.5
52 Week High (Rs.) 35.10 (12-Nov-18)
52 Week Low (Rs.) 11.40 (31-Jul-19)
Life Time high (Rs.) 115.00 (10-Aug-15)
Life Time low (Rs.) 0.87 (28-May-03)
Exchange Symbol MARKSANS (NSE)
Average Daily Movement [ADM] 1.06
Average Volume [20 days](No. of shares) 631377
Market Cap (Rs. in Cr) 599.64 (Cr)
1 Month Return (%) -3.61
P/E Ratio (x) 7.68
% of Promoter holding pledged 0.00

SHARE PRICE CHART

We recommend to use only Weekly and Monthly charts. Daily charts are also given which are used for exits.

We do not recommend daily/intraday minute hourly charts.

Why should you follow Weekly & Monthly levels - The major levels come from weekly and monthly charts which the FII, fund managers usually use for entry and profit booking.

MARKSANS PHARMA, NSE, INDIA

 

QUARTERLY RESULTS

Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Quarterly Quarterly Quarterly Quarterly Quarterly Quarterly
Source Of Info (AR = Annual Report, PR = Press Release)
Net Sales/Income from operations
Other Operating Income
Total Income From Operations
Increase/Decrease in Stocks
Consumption of Raw Materials
Purchase of Traded Goods
Employees Cost
Depreciation
Other Expenses
Total Expenditure
Operating Profit
Other Income
P/L Before Int., Excpt. Items & Tax
Interest
P/L Before Exceptional Items & Tax
P/L Before Tax
Tax
P/L After Tax from Ordinary Activities
PAT
Minority Interest
Net Profit/(Loss) For the Period
Equity Share Capital
Reserves
Equity Dividend Rate (%)
EPS (Rs.) [After Extraordinary items]
EPS (Rs.) [Before Extraordinary items]
 

RATIO ANALYSIS

Among all the ratios these are the most important ratios to look before investing in a company.
Get the latest key Financial Ratios and the Ratio Analysis of to gauge the overall financial health of a company before investing.

Name Ratio Good/Not Good Description
Current Ratio (x) 3.78 > 2 is Good,
< 2 is Not Good
A liquidity ratio that measures a companys ability to pay short-term obligations. The higher the current ratio, the more capable the company is of paying its obligations.
Quick Ratio (x) 1.70 > 1 is Good,
< 1 is Not Good
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets
Dividend Yield (%) 0.34 > 1.5 is Good,
< 1.5 is Not Good
A financial ratio that shows how much a company pays out in dividends each year relative to its share price. Dividend yield is calculated as annual dividends per share divided by market price per share.
Interest Coverage Ratio (x) 14.16 > 2 is Good,
< 2 is Not Good
(For Banks & NBFC this is not Valid)
It is used to determine how easily a company can pay interest on outstanding debt. It is calculated by dividing a companys EBIT by the interest expenses.
Debt Equity Ratio (x) 0.20 < 2 is Good,
> 2 is Not Good
(For Banks & NBFC this is not Valid)
A measure of a companys financial leverage calculated by dividing its total liabilities by stockholders equity. The debt/equity ratio also depends on the industry in which the company operates.
Return On Asset (%) 11.51 > 5% is Good,
< 5% is Not Good
An indicator of how efficient management is at using its assets to generate earnings. Calculated by dividing a companys annual earnings by its total assets
Return On Equity (%) 14.82 > 18% is Good,
< 18% is Not Good
Also called Return on networth, it measures a companys profitability by revealing how much profit a company generates with the money shareholders have invested, it is calculated by dividing the net profit after tax by shareholder's fund For high growth companies you should expect a higher ROE.

For investors interested in MARKSANS PHARMA find all important information on MARKSANS PHARMA share price, peer comparison and analysis.

 

DIVIDEND

 

Get a glimpse into the dividend history-payout amount of MARKSANS, interim dividend and the latest dividend announcements by MARKSANS in the last 5 years.

# Announcement Date Ex-Date Amount Interim/Final
1 29-May-2019 19-Sep-2019 0.05 Final
2 30-May-2018 19-Sep-2018 0.05 Final
3 01-Jun-2017 19-Sep-2017 0.05 Final
4 31-May-2016 22-Sep-2016 0.12 Final
5 01-Jun-2015 23-Sep-2015 0.12 Final
6 29-May-2014 18-Sep-2014 0.10 Final
 

PROMOTER SHAREHOLDING

Look up all relevant information on shareholding pattern of MARKSANS, the change in shareholding as compared to last quarter, Promoters shareholding%, persons holding more than 1% shares of the company.

Shareholding PatternSep-19Jun-19Mar-19Dec-18Sep-18
Promoter and Promoter Group (%)48.2548.2548.2548.2548.25
Indian48.2548.2548.2548.2548.25
ForeignNILNILNILNILNIL
Institutions (%)3.123.694.074.094.56
FII2.372.662.722.622.98
DII0.751.031.351.481.58
NonInstitutions (%)48.6448.0647.6847.6647.19
Bodies CorporateNILNILNILNILNIL
Others48.6448.0647.6847.6647.19
CustodiansNILNILNILNILNIL
Total no. of shares (cr.)40.9340.9340.9340.9340.93
 

PUBLIC SHAREHOLDING

Study of the shareholding pattern of a company is a very important part of fundamental analysis. The shareholding pattern is a determinant of the market capitalization of the stock and is an indicator of whether the stock valuation is justified or not. Know the Public shareholding % for the last quarter as announced by the company.

Persons holding securities more than 1% of total number of shares under category Public Shareholding.CategoryJun-16Mar-16Dec-15Sep-15Mar-17
MARK SALDANHAPromoters48.2548.25NILNIL48.25
Bodies CorporateNonPromoters4.655.314.96NIL5.13
FOREIGN INSTITUTIONAL INVESTORSNonPromoters13.627.94NILNIL4.70
MONDRIAN EMERGING MARKET SMALL CAP EQUITY FUNDNonPromotersNILNILNILNIL2.48
NRINonPromotersNILNILNILNIL1.24
ONTARIO PENSION BOARD - MONDRIAN INVESTMENT PARTNER LIMITEDNonPromotersNILNILNILNIL1.15
MONDRIAN EMERGING MARKETS SMALL CAP EQUITY FUND,L.P.NonPromoters2.281.80NILNILNIL
WASATCH EMERGING MARKETS SMALL CAP FUNDNonPromoters1.941.94NILNILNIL
CALIFORNIA PUBLIC EMPLOYEES' RETIREMENT SYSTEM, MANAGED BY WASATCH ADVISORS, INC.NonPromoters1.281.28NILNILNIL
Foreign Individuals or NRINonPromoters1.091.02NILNILNIL
Mark SaldanhanPromotersNILNIL48.25NILNIL
FIISNonPromotersNILNIL9.19NILNIL
Wasatch Emerging Markets Small Cap FundNonPromotersNILNIL2.182.42NIL
Mondrian Emerging Markets Small Cap Equity Fund L.P.NonPromotersNILNIL1.801.80NIL
California Public Employees Retirement System Managed by Wasatch Advisors Inc.NonPromotersNILNIL1.281.28NIL
Non Resident IndiansNonPromotersNILNIL1.08NILNIL
Foreign CompaniesNonPromotersNILNIL1.02NILNIL
Mark SaldanhaPromotersNILNILNIL48.25NIL
 

COMPANY PROFILE

Study MARKSANS management, company profile, ownership, management, Board of Directors and Organization Structure of MARKSANS

COMPANY PROFILE OF MARKSANS PHARMA, NSE, INDIA
Date of Incorporation 16-Apr-1992
Date of Listing 21-Jan-2002
Management
NameDesignation
Mark Saldanha Chairman & Managing Director
Ajay S Joshi Independent Director
Naresh B Wadhwa Independent Director
Seetharama R Buddharaju Independent Director
Vinay Gopal Nayak Whole Time Director
Sandra Saldanha Whole Time Director
Registered Office Address
11th Floor, Grandeur,Veera Desai Extension Road,Oshiwara, Andheri (West),, 400053, Mumbai, Maharashtra, India,
Website
http://www.marksanspharma.com
 

PEERS PRICE COMPARISION

# Company Name Open High Low Last Price Prv Price Change % Chng
1 MARKSANS PHARMA 45.50 46.20 44.75 45.25 45.25 0 0.00
2 SUVEN 222.05 230.40 218.10 221.15 221.15 0 0.00
3 GLAXO PHARMA 2464.00 2474.00 2436.30 2451.80 2451.80 0 0.00
4 NATCO PHARMA 995.95 995.95 983.00 986.70 986.70 0 0.00
5 ALKEM LABORATORIES 1841.00 1843.00 1821.00 1825.00 1825.00 0 0.00
6 VENUS REMEDIES 104.05 104.15 103.00 103.50 103.50 0 0.00
7 JUBILANT 657.60 662.85 641.60 643.70 643.70 0 0.00
8 PIRAMAL ENTERPRISES 2746.00 2774.90 2725.25 2761.50 2761.50 0 0.00
9 BLISS GVS 175.00 178.90 168.60 176.85 176.85 0 0.00
10 SHILPA MEDICARE 659.50 663.90 645.25 656.85 656.85 0 0.00
11 PROCTER GAMBLE HEALTH 1015.50 1072.00 1015.50 1064.30 1064.30 0 0.00
12 SYNGENE 495.10 503.65 491.00 493.95 493.95 0 0.00
13 IPCA 500.00 503.45 493.00 495.55 495.55 0 0.00
14 OPTO CIRCUITS 6.95 7.00 6.90 6.95 6.95 0 0.00
15 ALEMBIC PHARMA 500.00 501.70 497.00 500.30 500.30 0 0.00
16 CAPLIN POINT 700.40 707.50 690.20 697.90 697.90 0 0.00
17 KOPRAN 71.30 72.00 70.50 70.90 70.90 0 0.00
18 RPG LIFE 387.55 405.00 387.55 396.80 396.80 0 0.00
19 SPARC 370.40 374.80 365.50 367.85 367.85 0 0.00
20 FDC 183.10 188.10 183.10 186.75 186.75 0 0.00
21 NECTAR LIFESCIENCES 27.65 27.65 26.95 27.20 27.20 0 0.00
22 VIMTA LABS 128.40 130.40 128.40 129.00 129.00 0 0.00
23 JB CHEMICALS 280.25 283.15 275.00 275.90 275.90 0 0.00
24 PFIZER 1728.80 1730.05 1711.00 1717.15 1717.15 0 0.00
25 BROOKS LAB 107.00 112.50 107.00 108.80 108.80 0 0.00
26 DISHMAN 288.20 304.20 278.00 301.20 301.20 0 0.00
27 MOREPEN LAB 16.75 17.00 16.50 16.60 16.60 0 0.00
28 SANOFI INDIA 4208.95 4230.00 4200.00 4213.30 4213.30 0 0.00

CIN: U67190WB2003PTC096617. Trading in Commodities is done through our Group Company Dynamic Commodities Pvt. Ltd. The company is also engaged in Proprietory Trading apart from Client Business.
“2019 © COPYRIGHT DYNAMIC EQUITIES PVT. LTD.”

Disclaimer: There is no guarantee of profits or no exceptions from losses. The investment advice provided are solely the personal views of the research team. You are advised to rely on your own judgment while making investment / Trading decisions. Past performance is not an indicator of future returns. Investment is subject to market risks. You should read and understand the Risk Disclosure Documents before trading/Investing.

Disclosure: We, Dynamic Equities Private Limited are also engaged in Proprietory Trading apart from Client Business. In case of any complaints/grievances, clients may write to us at compliance@dynamiclevels.com

  • Download our Mobile App
  • Available on Google Play
  • Available on App Store
  • RSS